-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
In order to further strengthen the medical security work for the prevention and control of the new crown pneumonia epidemic, the Office of the National Medical Insurance Bureau issued the "Notice on Effectively Doing a Good Job in the Current Epidemic Prevention and Control Medical Security Work" on the 21st, clarifying that the relevant expenses incurred by the insured in designated primary medical institutions shall be based on overall planning.
According to the current regulations of the region, the cost of purchasing new coronavirus antigen detection reagents at designated retail pharmacies can be paid using personal accounts
.
According to the current regulations of the region, the cost of purchasing new coronavirus antigen detection reagents at designated retail pharmacies can be paid using personal accounts
.
The notice clarifies that all provincial medical insurance departments should adjust and optimize the medical security policies and measures for epidemic prevention and control in a timely manner, and temporarily incorporate the novel coronavirus antigen detection reagents and corresponding detection items into the catalogue of basic medical insurance medical service items in their provinces according to procedures, and continue to standardize and optimize public medical care.
Institutional pricing policy for COVID-19 antigen testing services
.
Institutional pricing policy for COVID-19 antigen testing services
.
All provincial medical insurance departments should refer to the relevant requirements and temporarily include the newly added drugs in the"New Coronavirus Pneumonia Diagnosis and Treatment Plan (Trial Version 9)" into the payment scope of the provincial medical insurance fund; The medical insurance payment shall be stopped from the date of the release of the latest version of the diagnosis and treatment plan
.
.
For the newly added naimatevir tablets/ritonavir tablets, the medical institutions shall purchase them according to the price agreed between the enterprise and the relevant departments , and the medical insurance department shall make the payment according to the regulations .
The notice clarifies that it supports the normal operation of medical institutions in severely affected areas, and if necessary, prepays part of the new crown treatment funds according to the procedures
.
At the same time, it is necessary to ensure the cost of new coronavirus vaccines and vaccinations, implement price policies for nucleic acid and antigen testing items, and implement settlement and reimbursement policies such as "long-term prescriptions" and Internet diagnosis and treatment
.
.
At the same time, it is necessary to ensure the cost of new coronavirus vaccines and vaccinations, implement price policies for nucleic acid and antigen testing items, and implement settlement and reimbursement policies such as "long-term prescriptions" and Internet diagnosis and treatment
.
In order to further strengthen the medical security work for the prevention and control of the new crown pneumonia epidemic, the Office of the National Medical Insurance Bureau issued the "Notice on Effectively Doing a Good Job in the Current Epidemic Prevention and Control Medical Security Work" on the 21st, clarifying that the relevant expenses incurred by the insured in designated primary medical institutions shall be based on overall planning.
According to the current regulations of the region, the cost of purchasing new coronavirus antigen detection reagents at designated retail pharmacies can be paid using personal accounts
.
According to the current regulations of the region, the cost of purchasing new coronavirus antigen detection reagents at designated retail pharmacies can be paid using personal accounts
.
The notice clarifies that all provincial medical insurance departments should adjust and optimize the medical security policies and measures for epidemic prevention and control in a timely manner, and temporarily incorporate the novel coronavirus antigen detection reagents and corresponding detection items into the catalogue of basic medical insurance medical service items in their provinces according to procedures, and continue to standardize and optimize public medical care.
Institutional pricing policy for COVID-19 antigen testing services
.
Institutional pricing policy for COVID-19 antigen testing services
.
All provincial medical insurance departments should refer to the relevant requirements and temporarily include the newly added drugs in the "New Coronavirus Pneumonia Diagnosis and Treatment Plan (Trial Version 9)" into the payment scope of the provincial medical insurance fund; The medical insurance payment shall be stopped from the date of the release of the latest version of the diagnosis and treatment plan
.
.
For the newly added naimatevir tablets/ritonavir tablets, the medical institutions shall purchase them according to the price agreed between the enterprise and the relevant departments , and the medical insurance department shall make the payment according to the regulations .
The notice clarifies that it supports the normal operation of medical institutions in severely affected areas, and if necessary, prepays part of the new crown treatment funds according to the procedures
.
At the same time, it is necessary to ensure the cost of new coronavirus vaccines and vaccinations, implement price policies for nucleic acid and antigen testing items, and implement settlement and reimbursement policies such as "long-term prescriptions" and Internet diagnosis and treatment
.
.
At the same time, it is necessary to ensure the cost of new coronavirus vaccines and vaccinations, implement price policies for nucleic acid and antigen testing items, and implement settlement and reimbursement policies such as "long-term prescriptions" and Internet diagnosis and treatment
.
In order to further strengthen the medical security work for the prevention and control of the new crown pneumonia epidemic, the Office of the National Medical Insurance Bureau issued the "Notice on Effectively Doing a Good Job in the Current Epidemic Prevention and Control Medical Security Work" on the 21st, clarifying that the relevant expenses incurred by the insured in designated primary medical institutions shall be based on overall planning.
According to the current regulations of the region, the cost of purchasing new coronavirus antigen detection reagents at designated retail pharmacies can be paid using personal accounts
.
According to the current regulations of the region, the cost of purchasing new coronavirus antigen detection reagents at designated retail pharmacies can be paid using personal accounts
.
The notice clarifies that all provincial medical insurance departments should adjust and optimize the medical security policies and measures for epidemic prevention and control in a timely manner, and temporarily incorporate the novel coronavirus antigen detection reagents and corresponding detection items into the catalogue of basic medical insurance medical service items in their provinces according to procedures, and continue to standardize and optimize public medical care.
Institutional pricing policy for COVID-19 antigen testing services
.
Institutional pricing policy for COVID-19 antigen testing services
.
All provincial medical insurance departments should refer to the relevant requirements and temporarily include the newly added drugs in the "New Coronavirus Pneumonia Diagnosis and Treatment Plan (Trial Version 9)" into the payment scope of the provincial medical insurance fund; The medical insurance payment shall be stopped from the date of the release of the latest version of the diagnosis and treatment plan
.
medicines medicines medicines.
For the newly added naimatevir tablets/ritonavir tablets, the medical institutions shall purchase them according to the price agreed between the enterprise and the relevant departments , and the medical insurance department shall make the payment according to the regulations .
Enterprise Enterprise Enterprise Procurement Procurement Procurement The notice clarifies that it supports the normal operation of medical institutions in severely affected areas, and if necessary, prepays part of the new crown treatment funds according to the procedures
.
At the same time, it is necessary to ensure the cost of new coronavirus vaccines and vaccinations, implement price policies for nucleic acid and antigen testing items, and implement settlement and reimbursement policies such as "long-term prescriptions" and Internet diagnosis and treatment
.
.
At the same time, it is necessary to ensure the cost of new coronavirus vaccines and vaccinations, implement price policies for nucleic acid and antigen testing items, and implement settlement and reimbursement policies such as "long-term prescriptions" and Internet diagnosis and treatment
.
